CEACAM5 and neoplasm: Carbohydrate antigen 19–9 (CA 19–9) and carcinoembryonic antigen (CEA) are the most studied tumor markers in BTC and are increased in 85% and 40% of patients, respectively, compared to healthy controls [6].